Richard D. Finkelman

3.5k total citations
45 papers, 2.8k citations indexed

About

Richard D. Finkelman is a scholar working on Molecular Biology, Periodontics and Rheumatology. According to data from OpenAlex, Richard D. Finkelman has authored 45 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Periodontics and 10 papers in Rheumatology. Recurrent topics in Richard D. Finkelman's work include Oral microbiology and periodontitis research (14 papers), Bone Metabolism and Diseases (11 papers) and Bone and Dental Protein Studies (8 papers). Richard D. Finkelman is often cited by papers focused on Oral microbiology and periodontitis research (14 papers), Bone Metabolism and Diseases (11 papers) and Bone and Dental Protein Studies (8 papers). Richard D. Finkelman collaborates with scholars based in United States, United Kingdom and Hungary. Richard D. Finkelman's co-authors include David J. Baylink, Subburaman Mohan, William T. Butler, Samuel E. Lynch, William V. Giannobile, Manuel P. Mark, Charles W. Prince, Steffen Gay, Jean‐Victor Ruch and Søren Jepsen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Richard D. Finkelman

44 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard D. Finkelman United States 24 1.1k 724 574 569 485 45 2.8k
Shinichiro Oida Japan 28 952 0.8× 894 1.2× 407 0.7× 649 1.1× 168 0.3× 104 2.2k
Janice E. Berry United States 33 1.3k 1.2× 797 1.1× 286 0.5× 675 1.2× 936 1.9× 50 3.0k
R. Bruce Rutherford United States 28 965 0.9× 626 0.9× 655 1.1× 818 1.4× 168 0.3× 50 3.1k
Flávia Q. Pirih United States 27 459 0.4× 281 0.4× 897 1.6× 263 0.5× 622 1.3× 77 2.5k
Sunday O. Akintoye United States 23 406 0.4× 374 0.5× 385 0.7× 175 0.3× 321 0.7× 53 1.8k
Masanori Koide Japan 28 1.5k 1.4× 339 0.5× 168 0.3× 125 0.2× 951 2.0× 58 2.7k
Leonard Rifas United States 27 1.7k 1.5× 630 0.9× 98 0.2× 112 0.2× 941 1.9× 49 3.5k
Bjorn Steffensen United States 30 661 0.6× 267 0.4× 462 0.8× 494 0.9× 522 1.1× 66 2.7k
Noriaki Ono United States 30 1.9k 1.7× 705 1.0× 139 0.2× 217 0.4× 697 1.4× 83 3.5k
Ron Zohar Canada 18 577 0.5× 634 0.9× 261 0.5× 268 0.5× 206 0.4× 34 1.7k

Countries citing papers authored by Richard D. Finkelman

Since Specialization
Citations

This map shows the geographic impact of Richard D. Finkelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Finkelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Finkelman more than expected).

Fields of papers citing papers by Richard D. Finkelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Finkelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Finkelman. The network helps show where Richard D. Finkelman may publish in the future.

Co-authorship network of co-authors of Richard D. Finkelman

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Finkelman. A scholar is included among the top collaborators of Richard D. Finkelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Finkelman. Richard D. Finkelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zimran, Ari, Jaco Botha, Richard Eastell, et al.. (2025). Bone mineral density improvements in velaglucerase alfa-treated patients with Gaucher disease: Real-world data from the Gaucher Outcome Survey (GOS). Molecular Genetics and Metabolism. 144(2). 108991–108991.
2.
Khan, Aliya, Intekhab Ahmed, Claudia Gagnon, et al.. (2024). Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1–84) in hypoparathyroidism. JBMR Plus. 8(3). ziad010–ziad010. 2 indexed citations
3.
Ing, Steven, Richard D. Finkelman, Ping He, et al.. (2023). A Phase I Randomized Trial of Once‐Daily Versus Twice‐Daily Recombinant Human Parathyroid Hormone (1‐84) for Hypoparathyroidism. JBMR Plus. 7(7). e10758–e10758. 2 indexed citations
4.
Song, Ivy, Richard D. Finkelman, & Lan Lan. (2020). A Pharmacokinetic Bridging Study to Compare Systemic Exposure to Budesonide between Budesonide Oral Suspension and ENTOCORT EC in Healthy Individuals. Drugs in R&D. 20(4). 359–367. 12 indexed citations
5.
Finkelman, Richard D. & Glen Clack. (2012). The Androgen Receptor in Castration-Resistant Prostate Cancer: Still a Clinical Opportunity?. Journal of Cancer Science & Therapy. 1(S5). 2 indexed citations
6.
Hannon, R.A., Richard D. Finkelman, Glen Clack, et al.. (2012). Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study. Bone. 50(4). 885–892. 21 indexed citations
7.
Reddy, Michael S., Marjorie K. Jeffcoat, Nicolaas C. Geurs, et al.. (2003). Efficacy of Controlled‐Release Subgingival Chlorhexidine to Enhance Periodontal Regeneration. Journal of Periodontology. 74(4). 411–419. 9 indexed citations
8.
Henke, Curtis J., Robert J. Genco, William J. Killoy, et al.. (2001). An economic evaluation of a chlorhexidine chip for treating chronic periodontitis. The Journal of the American Dental Association. 132(11). 1557–1569. 15 indexed citations
9.
Stabholz, Adam, Lior Shapira, D. Mahler, et al.. (2000). Using the PerioChip in treating adult periodontitis: an interim report.. PubMed. 21(4). 325–8, 330, 332 passim; quiz 338. 6 indexed citations
10.
Lissovoy, Gregory de, et al.. (1999). THE COST-EFFECTIVENESS OF A NEW CHLORHEXIDINE DELIVERY SYSTEM IN THE TREATMENT OF ADULT PERIODONTITIS. The Journal of the American Dental Association. 130(6). 855–862. 19 indexed citations
11.
Finkelman, Richard D. & Ray Williams. (1998). Local delivery of chemotherapeutic agents in periodontal therapy: Has its time arrived?1. Journal Of Clinical Periodontology. 25(11). 943–946. 7 indexed citations
12.
Giannobile, William V., Rafael Hernández, Richard D. Finkelman, et al.. (1996). Comparative effects of plateletderived growth factor‐BB and insulin‐like growth factor‐I, individually and in combination, on periodontal regeneration in Macaca fascicularis. Journal of Periodontal Research. 31(5). 301–312. 172 indexed citations
13.
Giannobile, William V., Richard D. Finkelman, & Samuel E. Lynch. (1994). Comparison of Canine and Non‐Human Primate Animal Models for Periodontal Regenerative Therapy: Results Following a Single Administration of PDGF/IGF‐I. Journal of Periodontology. 65(12). 1158–1168. 169 indexed citations
14.
Selvig, Knut A., Ulf M. E. Wikesjö, Gary Bogle, & Richard D. Finkelman. (1994). Impaired early bone formation in periodontal fenestration defects in dogs following application of insulin‐like growth factor (II). Basic fibroblast growth factor and transforming growth factor beta 1. Journal Of Clinical Periodontology. 21(6). 380–385. 42 indexed citations
15.
Lynch, Samuel E., Stephen B. Trippel, Richard D. Finkelman, et al.. (1994). The combination of platelet‐derived growth factor‐BB and insulin‐like growth factor‐I stimulates bone repair in adult Yucatan miniature pigs. Wound Repair and Regeneration. 2(3). 182–190. 20 indexed citations
16.
Dequeker, J., Subburaman Mohan, Richard D. Finkelman, Jeroen Aerssens, & David J. Baylink. (1993). Generalized osteoarthritis associated with increased insulin‐like growth factor types i and ii and transforming growth factor β in cortical bone from the iliac crest. possible mechanism of increased bone density and protection against osteoporosis. Arthritis & Rheumatism. 36(12). 1702–1708. 166 indexed citations
17.
Finkelman, Richard D., T. L. Munsat, Harvey N. Mandell, Lester S. Adelman, & Eric L. Logigian. (1993). Neuromuscular manifestations of Wegener's granulomatosis. Neurology. 43(3_part_1). 617–617. 6 indexed citations
18.
Jepsen, Søren, et al.. (1992). Transforming growth factor-β1 mRNA in neonatal ovine molars visualized by in situ hybridization: Potential role for the stratum intermedium. Archives of Oral Biology. 37(8). 645–653. 23 indexed citations
19.
Finkelman, Richard D., Norman H. Bell, Donna D. Strong, L. M. Demers, & David J. Baylink. (1992). Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss.. Proceedings of the National Academy of Sciences. 89(24). 12190–12193. 101 indexed citations
20.
Mark, Manuel P., William T. Butler, Charles W. Prince, Richard D. Finkelman, & Jean‐Victor Ruch. (1988). Developmental expression of 44-kDa bone phosphoprotein (osteopontin) and bone γ-carboxyglutamic acid (Gla)-containing protein (osteocalcin) in calcifying tissues of rat. Differentiation. 37(2). 123–136. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026